Baxter’s BioScience division is a leading producer of both plasma-based and recombinant clotting factors for hemophilia, as well as biopharmaceuticals used to treat immune deficiencies, alpha 1 antitrypsin deficiency and other blood-related disorders. Baxter also produces vaccines for the prevention of infectious diseases, as well as biosurgery products used ...
From Baxter - 43 days ago
- save job -
block
